BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 37382966)

  • 1. The PML hub: An emerging actor of leukemia therapies.
    Rérolle D; de Thé H
    J Exp Med; 2023 Aug; 220(8):. PubMed ID: 37382966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promyelocytic Leukemia Protein, a Protein at the Crossroad of Oxidative Stress and Metabolism.
    Tessier S; Martin-Martin N; de Thé H; Carracedo A; Lallemand-Breitenbach V
    Antioxid Redox Signal; 2017 Mar; 26(9):432-444. PubMed ID: 27758112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Post-translational Modifications of PML in Regulating the Functions of Nuclear Bodies --Review].
    Ma XF; Tan Y; Li SF; Jin W; Wang KK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1696-1700. PubMed ID: 31607334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PML nuclear bodies: assembly and oxidative stress-sensitive sumoylation.
    Sahin U; de Thé H; Lallemand-Breitenbach V
    Nucleus; 2014; 5(6):499-507. PubMed ID: 25482067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress-induced assembly of PML nuclear bodies controls sumoylation of partner proteins.
    Sahin U; Ferhi O; Jeanne M; Benhenda S; Berthier C; Jollivet F; Niwa-Kawakita M; Faklaris O; Setterblad N; de Thé H; Lallemand-Breitenbach V
    J Cell Biol; 2014 Mar; 204(6):931-45. PubMed ID: 24637324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PML Nuclear bodies: the cancer connection and beyond.
    Abou-Ghali M; Lallemand-Breitenbach V
    Nucleus; 2024 Dec; 15(1):2321265. PubMed ID: 38411156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PML nuclear bodies, membrane-less domains acting as ROS sensors?
    Niwa-Kawakita M; Wu HC; Thé H; Lallemand-Breitenbach V
    Semin Cell Dev Biol; 2018 Aug; 80():29-34. PubMed ID: 29157919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promyelocytic Leukemia Protein (PML) Controls Listeria monocytogenes Infection.
    Ribet D; Lallemand-Breitenbach V; Ferhi O; Nahori MA; Varet H; de Thé H; Cossart P
    mBio; 2017 Jan; 8(1):. PubMed ID: 28074026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral DNA Binding Protein SUMOylation Promotes PML Nuclear Body Localization Next to Viral Replication Centers.
    Stubbe M; Mai J; Paulus C; Stubbe HC; Berscheminski J; Karimi M; Hofmann S; Weber E; Hadian K; Hay R; Groitl P; Nevels M; Dobner T; Schreiner S
    mBio; 2020 Mar; 11(2):. PubMed ID: 32184235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Tale of Usurpation and Subversion: SUMO-Dependent Integrity of Promyelocytic Leukemia Nuclear Bodies at the Crossroad of Infection and Immunity.
    Patra U; Müller S
    Front Cell Dev Biol; 2021; 9():696234. PubMed ID: 34513832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The functional roles of PML nuclear bodies in genome maintenance.
    Chang HR; Munkhjargal A; Kim MJ; Park SY; Jung E; Ryu JH; Yang Y; Lim JS; Kim Y
    Mutat Res; 2018 May; 809():99-107. PubMed ID: 28521962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RING tetramerization is required for nuclear body biogenesis and PML sumoylation.
    Wang P; Benhenda S; Wu H; Lallemand-Breitenbach V; Zhen T; Jollivet F; Peres L; Li Y; Chen SJ; Chen Z; de Thé H; Meng G
    Nat Commun; 2018 Mar; 9(1):1277. PubMed ID: 29599493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of component exchange at PML nuclear bodies.
    Weidtkamp-Peters S; Lenser T; Negorev D; Gerstner N; Hofmann TG; Schwanitz G; Hoischen C; Maul G; Dittrich P; Hemmerich P
    J Cell Sci; 2008 Aug; 121(Pt 16):2731-43. PubMed ID: 18664490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PML nuclear bodies: from architecture to function.
    Lallemand-Breitenbach V; de Thé H
    Curr Opin Cell Biol; 2018 Jun; 52():154-161. PubMed ID: 29723661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of nuclear bodies in apoptosis signalling.
    Krieghoff-Henning E; Hofmann TG
    Biochim Biophys Acta; 2008 Nov; 1783(11):2185-94. PubMed ID: 18680765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs.
    Peche LY; Scolz M; Ladelfa MF; Monte M; Schneider C
    Cell Death Differ; 2012 Jun; 19(6):926-36. PubMed ID: 22117195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase 7 promotes PML sumoylation and is essential for PML nuclear body formation.
    Gao C; Ho CC; Reineke E; Lam M; Cheng X; Stanya KJ; Liu Y; Chakraborty S; Shih HM; Kao HY
    Mol Cell Biol; 2008 Sep; 28(18):5658-67. PubMed ID: 18625722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PML nuclear bodies and chromatin dynamics: catch me if you can!
    Corpet A; Kleijwegt C; Roubille S; Juillard F; Jacquet K; Texier P; Lomonte P
    Nucleic Acids Res; 2020 Dec; 48(21):11890-11912. PubMed ID: 33068409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Promyelocytic Leukemia Nuclear Bodies During HPV Infection.
    Guion LG; Sapp M
    Front Cell Infect Microbiol; 2020; 10():35. PubMed ID: 32154186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body language: the function of PML nuclear bodies in apoptosis regulation.
    Hofmann TG; Will H
    Cell Death Differ; 2003 Dec; 10(12):1290-9. PubMed ID: 12934066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.